‘Branded Generics’ as a strategy to limit cannibalization of pharmaceutical markets
Managerial and Decision Economics2007Vol. 28(4-5), pp. 251–265
Citations Over TimeTop 10% of 2007 papers
Abstract
Abstract This paper demonstrates how, by introducing a generic version of its previously patented product, a branded firm can influence the equilibrium in the generic segment of the market for the product. This in turn can increase the firm's profits from selling the branded version. We then use structural estimates from previous literature to calculate the magnitude of the effects in the generic and branded segments. Copyright © 2007 John Wiley & Sons, Ltd.
Related Papers
- → Model Development for Reliability Cannibalization(2017)2 cited
- → The performance of cannibalization policies in a maintenance system with spares, repair, and resource constraints(1986)37 cited
- → Technical Note—Cannibalization Policies for Multistate Systems(1977)7 cited
- Conceptualizing Cannibalization: The Case of Tourist Companies(2008)
- → Cannibalization revisited(2017)1 cited